Polio virus micro essay
Polio virus micro essay
Reading File
Searching the Web
poliovirus virology pathogenesis clinical features eradication 2024
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have excellent material from two authoritative textbooks (Harrison's Principles and Medical Microbiology 9e) plus current eradication data. Here is the full micro essay:
Poliovirus: A Micro Essay
Classification and Structure
Poliovirus is a member of the family Picornaviridae, genus Enterovirus. It is a small (27-30 nm), non-enveloped, icosahedral virus with a single-stranded, positive-sense RNA genome. The capsid is composed of four viral proteins (VP1-VP4), with VP1 being the dominant target of neutralizing antibody. Three serotypes exist - types 1, 2, and 3 - all transmissible to humans only. Because it lacks a lipid envelope, the virus is remarkably stable: resistant to stomach acid, proteases, bile, alcohol-based disinfectants, and standard detergents, and it can persist for days at room temperature. It is susceptible to chlorine-containing cleansers. The genome encodes a single polyprotein that is proteolytically cleaved by viral proteases into structural and enzymatic components, including an RNA-dependent RNA polymerase. Replication is rapid - the entire cycle can complete in as little as 3 to 4 hours, with up to 100,000 virions released per cell on lysis.
Transmission and Epidemiology
Poliovirus is transmitted almost exclusively by the fecal-oral route - ingestion of contaminated food or water is the primary mechanism. Oral-oral spread can also occur. Patients are most infectious just before and after symptom onset, when virus is present in both stool and throat. The incubation period ranges from 2-14 days, typically under one week. Asymptomatic shedding from the oropharynx can continue for up to 3 weeks, and from the gastrointestinal tract for up to 12 weeks - or more than 20 years in hypogammaglobulinemic patients. More than 90% of poliovirus infections are entirely subclinical.
Poor sanitation, crowded living conditions, and inadequate hygiene all amplify transmission. A counterintuitive epidemiological observation is that improved hygiene in industrialized nations delayed infection to older age groups, which paradoxically increased the severity of paralytic polio, since older children and adults who remained seronegative were more likely to develop paralysis upon first exposure.
Pathogenesis
The stages of poliovirus infection are well characterized and have served as a model for understanding enteroviruses broadly. After ingestion, the virus:
- Infects epithelial cells in the gastrointestinal mucosa and replicates in the tonsils and Peyer's patches.
- Spreads to regional lymph nodes, producing a primary viremia that seeds reticuloendothelial cells of the lymph nodes, spleen, and liver.
- A secondary viremia follows, distributing the virus to receptor-bearing target tissues.
- In a minority of cases, the virus reaches the central nervous system (CNS), most likely via the bloodstream, though peripheral nerve axonal transport (analogous to rabies virus) may also occur.
The poliovirus receptor is a member of the immunoglobulin superfamily. In the CNS, the virus is cytolytic for the motor neurons of the anterior horn of the spinal cord and the brainstem. Direct viral destruction - not immune-mediated inflammation - is the primary mechanism of cellular injury. The extent of paralysis depends on which motor neuron pools are affected and how many neurons are destroyed.
Clinical Spectrum
The spectrum of illness includes:
- Subclinical infection (>90% of cases) - no symptoms
- Abortive poliomyelitis - minor illness with fever, sore throat, and malaise; no neurological involvement
- Non-paralytic poliomyelitis (aseptic meningitis) - meningismus without paralysis
- Paralytic poliomyelitis (<1% of infections) - flaccid, asymmetric lower motor neuron paralysis, typically affecting the legs; the hallmark is loss of deep tendon reflexes with preserved sensation. Bulbar involvement can compromise respiratory muscles, historically requiring the iron lung for ventilatory support.
- Post-polio syndrome - decades after the initial infection, surviving motor neurons (already compensating for lost cells) may progressively fail, leading to new weakness. This is attributed to the combined loss of neurons to the original poliovirus infection and to normal aging.
Immunity
Humoral immunity is the central protective response. Secretory IgA prevents establishment of infection in the oropharynx and gut. Serum IgG prevents viremic spread to target tissues and confers lifelong serotype-specific protection. IgM appears early but wanes within 6 months. Cell-mediated immunity plays little role in protection - patients with impaired cellular immunity do not develop unusually severe disease - but agammaglobulinemia leads to fatal, progressive poliovirus infection, confirming that antibody is essential. Breast milk IgA can protect infants from infection.
Vaccines
Two vaccine strategies exist:
- Inactivated Polio Vaccine (IPV, Salk): Induces serum IgG that prevents viremia and paralysis; does not induce strong mucosal immunity; cannot cause vaccine-derived polio; preferred in polio-free countries.
- Oral Polio Vaccine (OPV, Sabin): Live attenuated strains; induces both humoral and mucosal (IgA) immunity; highly effective for community protection; cheap and easy to administer. However, attenuated strains can mutate during replication in the gut - primarily in the VP1 gene - reverting toward neurovirulence and generating circulating vaccine-derived polioviruses (cVDPVs). This is the primary complication of OPV use. A novel OPV type 2 (nOPV2) with a more genetically stabilized genome was developed to reduce this risk.
Eradication Efforts and Current Status
The Global Polio Eradication Initiative (GPEI) launched in 1988 has achieved a reduction of more than 99.9% in wild poliovirus (WPV) cases. Wild poliovirus type 2 was certified eradicated in 2015, and WPV type 3 in 2019. As of 2024, WPV type 1 remains endemic only in Afghanistan and Pakistan. In 2023, the WHO reported 12 AFP (acute flaccid paralysis) cases from WPV1 and 527 from cVDPVs. By October 2024, 62 WPV1 cases were confirmed, while cVDPV type 2 had caused paralysis in 182 individuals across 16 countries - including one confirmed case in Gaza - making vaccine-derived virus the dominant ongoing challenge. Poliovirus is also feared to persist in sewage for extended periods due to the virus's environmental hardiness, complicating environmental surveillance and containment.
Sources:
- Harrison's Principles of Internal Medicine, 22nd ed. (2025), Enterovirus section - Medical Microbiology, 9th ed. (Murray), Ch. 46 - Picornaviruses
- GPEI 2024 eradication update
- PMC polio epidemiology 2024
Larva migran micro
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Excellent - I have comprehensive material from Harrison's (22e), Goldman-Cecil, and Jawetz covering all forms. Here is the full micro essay:
Larva Migrans: A Micro Essay
Definition and Overview
Larva migrans is a syndrome in which helminth larvae - usually those normally parasitic in non-human hosts - accidentally infect humans and migrate through tissues without completing their normal life cycle or maturing into adult worms. Because humans are dead-end, non-permissive hosts, the larvae wander aimlessly, provoking intense inflammatory responses wherever they travel. The syndrome is classified by the anatomical compartment involved:
- Cutaneous larva migrans (CLM) - skin
- Visceral larva migrans (VLM) - internal organs
- Ocular larva migrans (OLM) - eye
- Neural larva migrans (NLM) - brain and CNS
1. Cutaneous Larva Migrans
Etiology
CLM ("creeping eruption") is caused most commonly by larvae of the dog and cat hookworm Ancylostoma braziliense, though A. caninum and Uncinaria stenocephala can also be responsible.
Life Cycle and Transmission
Adult worms reside in the intestines of dogs and cats and pass eggs in feces. The eggs embryonate in warm, moist soil. Filariform (infective, L3) larvae develop in the soil and actively penetrate human skin on contact - typically bare feet, buttocks, or hands. Warm, humid climates (tropical and subtropical regions) are required for larval survival in soil. Beaches and sandboxes frequented by animals are classic exposure sites. Children and travelers are most at risk.
Pathogenesis
In the animal host, hookworm larvae penetrate the dermis, enter the circulation, migrate to the lungs, ascend the bronchial tree, are swallowed, and mature in the gut. In humans, the larvae lack the collagenase enzymes needed to penetrate the basement membrane of the dermis and enter the vasculature. They are therefore trapped at the dermal-epidermal junction, where they burrow laterally and upward, advancing several centimeters per day along a tortuous, winding track. The surrounding eosinophilic infiltration causes pruritus and visible inflammation.
Clinical Features
The hallmark is an intensely pruritic, serpiginous (snake-like), erythematous, raised track in the skin that advances daily. Vesicles and bullae may form. Lesions can be multiple if the patient lay on contaminated ground. Any cutaneous surface may be affected. Without treatment, larvae die within weeks to a few months and skin lesions resolve spontaneously - but the pruritus is often intolerable.
Diagnosis
Clinical: the serpiginous migrating track is pathognomonic. Skin biopsy is unhelpful because the larva is typically several centimeters ahead of the visible track and is almost never captured histologically.
Treatment
- Ivermectin (single oral dose, 200 mcg/kg) - first-line, highly effective
- Albendazole (400 mg once daily for 3-7 days) - equally effective alternative
- Topical thiabendazole can relieve local symptoms but is less reliable
2. Visceral Larva Migrans (Toxocariasis)
Etiology
VLM is caused mainly by Toxocara canis (dog roundworm) and less commonly Toxocara cati (cat roundworm) or Ascaris suum (pig roundworm). Baylisascaris procyonis (raccoon roundworm) can cause a severe neural form.
Life Cycle and Transmission
T. canis completes its normal life cycle in dogs. In pregnant bitches, arrested larvae reactivate, crossing the placenta or passing through breast milk to infect puppies. Puppies shed large numbers of Toxocara eggs in feces. Eggs embryonate in soil over several weeks to become infectious. Humans - especially children aged under 5 years - ingest embryonated eggs from contaminated soil, sandpits, or playgrounds (sometimes via pica or geophagia). Occasionally ingestion of undercooked animal liver (paratenic host) transmits infection.
Pathogenesis
After ingestion, larvae hatch in the small intestine and penetrate the intestinal wall. Unlike in the permissive canine host (where larvae complete the tracheal migration cycle), in humans larvae migrate hematogenously to virtually any organ - liver, lungs, CNS, heart, muscle, and eye. They cannot develop into adult worms. As they migrate and eventually die, they elicit a powerful eosinophilic granulomatous response, with both immediate-type and delayed-type hypersensitivity components. The degree of illness depends on larval burden, tissue distribution, and host immune response.
Visceral larva migrans and ocular larva migrans are mutually exclusive clinical presentations, likely reflecting different larval burdens: higher worm burdens cause VLM with strong systemic immune activation, while a single larva reaching the eye produces OLM in a host with limited systemic exposure.
Clinical Features
Visceral larva migrans (age < 5 years):
- Low-grade fever, malaise, anorexia, weight loss
- Pulmonary: cough, wheezing, dyspnea - reflecting larval migration through lungs (resembling Löffler syndrome)
- Hepatosplenomegaly, sometimes causing right upper quadrant pain
- Peripheral eosinophilia, which can be extreme (up to 90% of WBC)
- Hypergammaglobulinemia, leukocytosis
- Rashes
- Rarely: myocarditis, nephritis, seizures, encephalopathy, or eosinophilic meningoencephalitis
- Symptoms typically resolve over 4-8 weeks even without treatment
Ocular larva migrans (age 5-10 years):
- A single larva invades the eye, usually the posterior segment
- Eosinophilic granulomatous mass forms around the larva, most commonly at the posterior pole of the retina
- Presents with unilateral visual disturbance, strabismus, eye pain
- May cause endophthalmitis, uveitis, chorioretinitis, or retinal detachment
- The retinal lesion can closely mimic retinoblastoma, and misdiagnosis has historically led to unnecessary enucleation
- Unlike VLM, OLM patients typically have no eosinophilia and no systemic symptoms
Neural larva migrans (Baylisascaris procyonis):
- Raccoon roundworm larvae are unusually large, aggressive migrators
- Cause devastating eosinophilic meningoencephalitis with encephalopathy, seizures, and permanent neurological damage
- Most reported cases are in children with raccoon exposure in North America
- Carries high mortality and morbidity; no reliably effective treatment
Diagnosis
- Eosinophilia + compatible clinical history (exposure to dogs/cats, pica, soil contact)
- ELISA for anti-Toxocara antibodies (larval-stage antigens) - standard confirmatory test; may be negative in OLM
- Immunoblot adds specificity
- Recombinant antigen-based ELISAs with improved sensitivity are emerging but not widely available
- Stool examination is useless: larvae never mature into egg-producing adults in humans
- Transient pulmonary infiltrates on chest X-ray in ~50% of symptomatic VLM
- For OLM: CT scan, fluorescein angiography; elevated anti-Toxocara antibodies in aqueous or vitreous humor relative to serum is diagnostic
- Tissue biopsy has very low sensitivity and is not recommended
Treatment
- Albendazole 400 mg twice daily for 5 days - recommended for acute toxocariasis
- Corticosteroids (e.g., prednisone 60 mg/day for 5 days) added when severe pulmonary, cardiac, or neurologic involvement is present
- OLM: corticosteroids (to reduce ocular inflammation) + albendazole, sometimes vitrectomy; requires specialist ophthalmologic input
- Most light infections are self-limited and resolve spontaneously
Prevention
- Prohibiting dog excreta in public parks and playgrounds
- Regular deworming of dogs and cats
- Discouraging pica behavior in children
- Handwashing after soil/pet contact
Comparative Summary
| Feature | Cutaneous LM | Visceral LM | Ocular LM | Neural LM |
|---|---|---|---|---|
| Causative organism | Ancylostoma braziliense | Toxocara canis/cati | Toxocara canis/cati | Baylisascaris procyonis |
| Route of infection | Skin penetration | Ingestion of eggs | Ingestion of eggs | Ingestion of eggs |
| Age group | Any (esp. children, travelers) | < 5 years | 5-10 years | Young children |
| Site of migration | Dermal-epidermal junction | Liver, lungs, CNS, heart | Posterior retina | Brain, spinal cord |
| Key feature | Serpiginous pruritic track | Eosinophilia, hepatosplenomegaly | Retinal granuloma, vision loss | Severe encephalitis |
| Eosinophilia | Mild/local | Marked (up to 90%) | Absent | Present |
| Treatment | Ivermectin / Albendazole | Albendazole ± steroids | Steroids + Albendazole | Albendazole (poor outcome) |
Sources:
- Harrison's Principles of Internal Medicine, 22nd ed. (2025), Ch. 238 - Goldman-Cecil Medicine, International ed., Ch. 327 - Toxocariasis
- Jawetz, Melnick & Adelberg's Medical Microbiology, 28th ed.
This is a shared conversation. Sign in to Orris to start your own chat.